dupilumab
R668-BP-1902
Phase 3 small_molecule completed
Quick answer
dupilumab for Bullous Pemphigoid is a Phase 3 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Bullous Pemphigoid
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed